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ABSTRACT
The physiological relationship between the various components of sleep
and its variation due to drug administration has been used as one of the primary
tools to analyze the performance of drug. A number of studies have been
performed in recent years in this direction. Electroencephalogram (EEG) has
been characterized with the help of variables ranging from measurements of the
duration of different sleep stages to the activities that define the stages
themselves. Advances in computer hardware and software have improved the
methods of data acquisition and storage. Analysis of long stretch of data has
always been a problem considering the time and storage.
The present study is aimed at characterizing sleep data from a subject
suffering from neurologic disorder. It also aims at identifying the effect of
Oxycodon a Narcotic drug on the subject during sleep. The data considered for
analysis is the output of a whole night recording. It is for a duration of six hours.
EEG signals are analyzed using random data analysis procedures. The
assumption of stationarity will be used as the basis of analysis. However the fact
that analysis on long stretch of data introducing nonstationarity will not be ruled
out. The analysis will be performed using Fast Fourier Transformation. Spectral
analysis will be used as the primary tool in identifying the activities of various
frequency components and its variation with time. The three parameters that will
be considered are Mean square values and correlation function in time domain,
Spectral analysis application in frequency domain and the probability density
and distribution functions in the amplitude domain.. Algorithms will be
developed for computing these parameters and other statistical properties.
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In recent years a number of sleep variables have been defined that characterizes
sleep. These variables range from measurements of the duration of the different
stages of sleep to measurements describing the evolution of sleep through the
night. Using these variables, a number of studies aimed at understanding the
fundamental properties of sleep in normal subjects have been performed. These
studies essentially concern sleep modifications produced by drugs or other
experimental manipulations. The physiological relationships between the
various components of sleep are still largely unknown. Advances in computer
hardware and software have led to improved acquisition and display, as well as
storage of sleep data. Strides have been made in computerized discrimination of
electroencephalographic (EEG) frequency patterns and specific wave complexes.
The present work aims at determining the time varying statistical properties of
various sleep variables in an attempt to characterize the variations in EEG
patterns following drug administration.
1.2 Normal Sleep Patterns
A normal sleep pattern has been realized after several studies of EEG. As soon as
the normal subject drifts into sleep the waking voluntary eye movements which
make huge deflections in electrooculogram(EOG) disappear and the high level of
muscle activity decreases. The background alpha rhythm disappears and the
subject enters Non Rapid Eye Movement (NREM) sleep stage 1. With the
appearance of sleep spindles and K-complexes, the subject enters NREM sleep
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stage 2. The K-complex, consisting of an initial negative wave, followed by a
positive wave, sometimes follows a sudden environmental stimulus such as
noise. Other K-complexes follow internal autonomic events such as bladder or
gastrointestinal contractions [1]. The sleep spindle is a burst of 12 to 15cps
activity lasting over one-half second. As NREM sleep progresses, delta activity
becomes more and more predominant, the subject enters NREM sleep stages 3
and 4.
After about two hours of NREM sleep, the subject abruptly enters Rapid
Eye Movement Sleep (REM) sleep. The EEG changes to a relatively low voltage,
mixed frequency pattern, and the chin EMG markedly decreases its activity.
Frequently a burst of theta activity heralds the onset of a REM period. The theta
waves which occur during REM sleep sometimes have a notch on the rising or
falling phase to give the picture of a sawteeth. These sawtooth waves, which are
characteristic of REM sleep, frequently occur during or just before an eye
movement. While some reports say that the eye movements of REM sleep are
unlike any eye movements recorded during wakefulness, others have described
somewhat similar eye movements during periods of daydreaming. Figure 1
presents a sample of typical polygraphic records from waking, REM sleep and
some NREM sleep stages.
Periods of NREM and REM alternate during the night. The cyclicity of this
alternation averages about 90 minutes for adults and 45 minutes for infants. In
adults the first NREM period is normally dominated by stage 4. NREM periods
in the early morning hours mainly consist of stage 2. The first REM period is
shorter and has fewer eye movements than the later REM periods. Four to six
REM periods occur during a night. As summarized in Table 1, about 20 to 25
percent of a night's sleep is spent in the REM state. Very slight decrease in REM
percentage and a somewhat larger decline in NREM stage 4 may occur with
Figure 1 All-night polygraphic recording. Top three channels monitor the
EEG; the next three, eye movements; and the bottom EMG.
Table 1 Sleep patterns in normal man
Average Sleep Sleep Stage Percentages
N Age Time W REM 1	 2	 3 4- Reference
Preadolescent males 18 9.5 565 min 1.5 24.3 .6.1 	 44.2 5.9 17.9 Ross et al. (1968)
Young adult males 16 24.2 0.9 24.1 5.4	 48.7 7.7 13.2 Williams et al. 	 (1964)
Young adult females 16 23.9 451 1.1 21.9 5.9 	 48.0 6.9 16.2 Williams et al. (1966)
Adult males 12 33.9 2.4 21.9 7.5 	 53.0 5.5 9.6 Agnew and Webb (1968a)
Middle aged males 16 54.1 436 4.1 22.8 10.9 	 51.1 8.4 2.7 Agnew et al. (1967)
Elderly (both sexes) 16 63.4 - 9.9 20.4 11.9 	 50.6 4.5 2.7 Agnew and Webb (1968b)
Aged males 16 80.2 365.8 20.1 4.2 	 53.9 17.2 4.5 Kahn and Fisher (1969)
Aged females 16 76.7 383.0 18.0 2.6 	 63.4 10.4 5.6 Kahn et al. (1970)
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increasing age. Table 1 also presents the average sleep patterns of different age
groups.
The sleep of normal human infant can be divided into two types. One type
is characterized by no eye or body movements and regular respirations while the
other type is associated with eye and body movements, irregular respiration and
spontaneous suckling [2]. The first type develops into NREM sleep , the latter
into REM. Sleep spindles first appear in the NREM EEG record. Unlike the adult,
the infant usually passes from wakefulness directly into REM sleep. At about
three months of age the infant begins to show the adult pattern of falling from
wakefulness into NREM sleep. EOG during neonatal REM sleep are not identical
to either eye movements of the waking newborn or of the adult REM state. It has
been suggested that the changes in both REM and NREM EEG can determine
conceptional age and neurological maturation in premature infants. In the case of
newborn 40 to 50 percent of the sleeping time is acquired by the REM stage.
1.3 Clinical Sleep Disorders
Thousands of miles of sleep EEG data have been accumulated, and countless
hours of effort have been expended by sleep researchers around the globe.
Considerable information has emerged from the sleep laboratories which can be
useful to the physician [3]. Some of the common disorders known are listed
below
a. Narcolepsy
This describes a condition of recurring, uncontrollable episodes of brief sleep.
This disorder usually begins in adolescence or young adulthood, it continues
throughout life but is generally thought to improve in later years [4]. In
narcoleptics REM occurs at, or soon after, the onset of sleep when compared to
normal sleep pattern. Many stimulant and antidepressant medications have been
6
used in the treatment of true narcolepsy, but nothing replaces an understanding
discussion with the patient and his family about the illness and ways they can
adjust themselves to it.
b. Cataplexy
Characterized by brief episodes of muscular weakness which are precipitated by
laughter, anger, or other emotional excitement. The degree of disability may
range in scope from a mere subjective feeling of weakness to almost total
paralysis.
c. Hypersomnia
The subject will have tendency to sleep for excessively long periods, either as an
extension of nocturnal sleep into the late morning or past noon, or at various
times during normal hours of wakefulness. Unlike narcoleptics, patients with
hypersomnia do not display the auxiliary symptoms of cataplexy and rarely
complain of disturbed nocturnal sleep [3].
d. Insomnia
Inability to fall asleep, frequent and prolonged awakenings, early morning
awakenings, in the absence of gross physical or psychological pathology is
probably one of the most common sleep disturbances. Sleep EEG studies indicate
that there is a physiological basis for the insomniac's complaints and it has been
found that these patients have significantly longer sleep latencies, shorter sleep
times and less efficient sleep.
e. Sudden Infant Death Syndrome (SIDS)
Is a sleep related phenomenon that has been strongly supported by the evidence
of a high incidence of infant mortality during sleep [5]. The typical clinical
syndrome is that of a generally healthy of 2 to 4 months of age who is put to
sleep in its crib at night and is found dead shortly thereafter or in the morning,
having died several hours before. Autopsy examination reveals no abnormalities
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recognized as cause for death. The automatic inspiratory-expiratory rhythmic
cycle is disrupted by recurrent periods of apnea. It is suggested that NREM sleep
stages in the infant might be more prone to be correlated with a prolonged apnea
than the REM sleep stage.
1.4 EEG and Drug Effect
Quantitative EEG methods have a well-documentated application in human
psychopharmacology. They are used to identify drugs which affect the central
nervous system, specify the times of drug activity, compare and classify drugs,
and relate EEG findings to other measured effects. The EEG signal is most
commonly quantified in fixed frequency bands, using power spectral density
analysis. Drug effects are defined as those EEG changes from pre-drug that differ
statistically from the changes after placebo.
In studies of newly developed drugs and low doses of known drugs, there
is frequently a problem in deciding whether there has been an effect on the EEG.
Probabilities are difficult to determine, since the many variables examined inflate
the likelihood of finding differences from placebo and standard statistical
adjustments are complicated by the high intercorrelations of EEG variables.
1.3 Visual and Computer Based Analysis
Sleep-waking patterns in the EEG have been studied in various species. Analysis
have been done using computers and visually. Visual analysis is based on the
interpretation of an individual with a good physiological background on sleep
characterizing the polygraphic records. The analysis depends on the individuals
view and the sleep criteria he considers. Visual analysis of the EEG remains
necessary and appropriate, but is time consuming and lacks quantification. The
expense and laboriousness of all-night polygraphy limits the number of subjects
8
and the number of nights which can be monitored in any single study. These
limitations in visual analysis have opened doors for computerized quantitative
analysis.
Various techniques for a computerized quantitative analysis of the EEG
have been developed. Computerized method enable on-line analysis and
objective classification of sleep-waking patterns recorded over large periods.
Frequency domain statistics like spectral density which accurately quantify the
sleep state by power-frequency distributions can be best done through computer
processing. If both visual and computer analysis are performed over the same
length of EEG, they seem to mutually influence each other [6]. Automatic
analysis does not replace visual analysis but is helpful in handling and
organizing the enormous amount of data obtained during very long records.
CHAPTER 2
TECHNIQUES FOR RANDOM DATA ANALYSIS
2.1 Random Processes
Data representing a random physical phenomenon cannot be described by an
explicit mathematical relationship because each observation of the phenomenon
will be unique. In other words, any given observation will represent only one of
many possible results which might have occurred.
Random processes may be categorized as being either stationary or
nonstationary. When a physical phenomenon is considered in terms of a random
process, the properties of the phenomenon can hypothetically be described at
any instant of time by computing average values over the collection of sample
functions which describe the random process. The random process is said to be
nonstationary if the mean value and the joint moment values vary with time. For
special cases when mean and the joint moment do not vary as time varies, the
random process is said to be weakly stationary or stationary in a wide sense [7].
When all possible moments and joint moments are time invariant, the random
process is said to be strongly stationary.
Nonstationary process include all random processes which do not meet
the requirements for stationarity. The statistical properties of nonstationary
random process are time varying functions which can be only determined by
performing instantaneous averages over the ensemble of sample functions
forming the process. Spectral analysis is a powerful tool in characterizing such
signal. Coherence spectra is used as a measure of correlation between two
simultaneous signals as a function of frequency. This can be used as a useful
method in medical applications.
9
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2.2 Basic Properties of Random Data
Four main types of statistical functions are used to describe the basic properties
of random data.
a. Mean square value
The mean square value describe the intensity of data. It is simply the average of
the squared values of the time history. The mean square value for a sample time
history x(t) is given by
T
ki• 	 =1im 1 	
r,
T 	 x2(t) dt
	T-> 430	 0
Physical data is a combination of time-invariant component and a fluctuating
component. The static component can be described by the mean value and
dynamic component by the variance which is the mean square value of the
fluctuation about the mean.
b. Probability density function
Probability density function describes the properties of data in the amplitude
domain. It tries to describe the probability that the data will assume a value
within some defined range at any instant of time. The probability that a sample
time history x(t) assumes a value within the range between x and (x + zix) may
be obtained by taking the ratio of Tx/T, where T is the total amount of time that
x(t) falls inside the range (x, x + tax) during an observation time T. The
probability density function p(x) can defined as
p(x)=1im lim 1/T(Tx /Ax )
Ax->0 T-> CO
The principal application for a probability density function measurement of
physical data is to establish a probabilistic description for the instantaneous
values of the data.
1 1
c. Autocorrelation Function
The autocorrelation function for random data describes the general dependence
of the values of the data at one time to the values at another. An estimate for the
autocorrelation between the values of a sample time history record x(t) at times t
and t + ti may be obtained by taking the product of the two values and averaging
over the observation time T. The autocorrelation function can be represented
mathematically as
T
	R x(t) lim 1 / T 	 x(t) x(t+t)dt
T-> OD 	 0
The autocorrelation function can be used to establish the influence of values at
any time over values at a future time. Autocorrelation measurement clearly
provides a powerful tool for detecting deterministic data which might be masked
in a random background.
d. Power spectral density function
Power spectral density function for random data describes the general frequency
composition of the data in terms of the spectral density of its mean square value.
A band-pass filter can be used to find the mean square value of a sample time
history in a frequency range between f and f + Af. The power spectral density
function can be represented as
	yx2[ f
, f+Af = lim 1 	 / T 	 x2 (t, f, Apdt
	T-> e0	 0
Power spectral density function is used to establish the frequency composition of
the data which inturn bears an important relationship to the basic characteristics
of the physical system involved. A final smooth estimate of the power spectral
density can be found by applying Harming Window Techniques.
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2.3 Analyzing techniques for nonstationary data
The processing techniques and the statistical formulas normally do not apply
when the data is nonstationary. Special considerations and procedures are
required for such analysis. Nonstationary data represent a class of data whose
statistical properties vary with time. Even though a vast majority of physical data
fall into the class of nonstationarity, many data can be assumed to be stationary
for the reasons of simplicity. The fundamental assumption made in this type of
analysis is that the power contains a stationary component coupled by a
nonstationary trend. Nonstationary conclusion is generally a negative statement
specifying the lack of stationary properties rather than defining the precise
nature of the nonstationarity [71.
In the past 3 types of models have been reported for analysing non-
stationary data.
a.Time-varying mean value
For a nonstationary data the mean values can be estimated using a computer. If
N different time intervals xi(t); i=1,2,3 N represent a nonstationary process
x(t), the estimate of mean value will vary over different choices of the N samples.
One must investigate how closely an arbitrary estimate will approximate the true
mean value. This can be done in two steps. The first step is to obtain mean value
for each record xi(t) as a function of t. After this has been done for N samples,
the average is determined by adding the records together and dividing by N.
b. Time-varying mean square value
The same analysis given for the time-varying mean is carried out to determine
the variation of nonstationary mean square value.
c. Time varying power spectra
The time-averaged power spectrum can be used for describing the time varying
spectral characteristics of an important special class of nonstationary random
13
processes which possess the following characteristics [7]
1. The lack of stationarity is due to deterministic time trends which are
represented in every sample function.
2. The time trends are very slow relative to the instantaneous fluctuations of the
data.
2.4 Frequency domain techniques
It is well known that when a quantity varies periodically with time it may be
'analyzed into its harmonic components'. The quantities may be pressure, light,
electricity etc. The variation in these quantities repeats itself at some basic
frequency and the disturbances having repetition frequencies equal to the
multiples of the basic frequency. Time and frequency appear as a related pair of
variables in all these cases. Transformation is a technique used to change the
representation of a parameter from one domain to another as shown in figure 2.
In the case of a signal it is the time and frequency which form the pair of domain.
2.4.1 Fourier & Fast Fourier transformation
The basic essence of Fourier transform of a waveform is to decompose or
separate the waveform into a sum of sinusoids of different frequencies. Figure 3
illustrates this interpretation. The pictorial representation of the Fourier
transform is a diagram which displays the amplitude and frequency of each of
the determined sinusoids. Mathematically, this relationship is stated as
CYO
S(f) =1S(t) e-i2 ft dt
-CO
where s(t) is the waveform to be decomposed into a sum of sinusoids, S(f) is the
fourier transform of s(t).

























Figure 2 Flow diagram relationship of conventional and transform analysis
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Figure 3 Interpretation of the Fourier transformation
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that the pair is amenable to digital computer computation. Discrete
Fourier transformation approximates Continuous Fourier transfolination as
closely as possible. Figure 4 illustrates a graphical development of the discrete
Fourier transformation. As shown in figure 4-(a) h(t) is the function whose
Discrete Fourier transform has to be found. It is sampled by multiplying with a
sampling function with a sample interval T. The waveform h(t) is sampled at a
frequency of at least twice the largest frequency component of h(t) in order to
avoid any loss of information. Sampled function is then truncated so that only
finite number of points are considered.
If there are N data points of a function and if we desire to determine the
amplitude of N separate sinusoids, then the computation time is proportional to
square of N. Even for high speed computers, computation of the discrete Fourier
transformation requires excessive machine time for large N.
To reduce the computational time of discrete Fourier transformation a
new mathematical algorithm known as Fast Fourier transformation was
developed. This algorithm makes the speed of computation time proportional to
Nlog2N times. If a computer takes half an hour to do a Discrete fourier
transformation on a data with N = 8192 samples, the calculation time required
by Fast Fourier transformation is only about five seconds.
2.5 Dynamics of Electroencephalography
Changes of the Electroencephalogram during sleep were already observed in the
early days of Electroencephalography [Caton, 1875; Burger, 1930]. Quantification
and explanation of EEG has been a problem for long times due to tremendous
amount of data generated during recording and unavailability of sophisticated
quantification methods. Modern developments in information theory and
statistical time series analysis have found their application also in
Figure 4 Graphical development of the discrete Fourier Transform
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Electroencephalography. These analytical techniques provide new insight into
the inherent structure and generation of neuroelectric activity, including mass
activity like the EEG [9]. The mathematically best-founded method is offered by
spectral analysis. The spectrum of single EEG records has already become
familiar by the use of various types of analog frequency analyzers [Grass and
Gibbs, 1938; Baldock and Walter, 1946; Suhara and Uemura, 1963].
Spectral analysis techniques have been widely used in interpreting the
inherent structure of EEG. The power spectrum displays the mean square value
or the average intensity of the EEG as a function of frequency. Figure 5 shows the
power spectra of an all-night sleep record. The cross-spectrum gives information
about the statistical interrelationship between two simultaneously recorded EEG
channels. The cross-spectrum is mathematically a complex quantity composed of
the cross-spectral amplitude, i.e. the average intensity of the activity shared by
the two records as a function of frequency, and the phase angle which gives the
average phase difference between the common frequency components. The
coherence spectrum provides a measure of the correlation between two EEG
records for each frequency band.
Spectral power density measurement has been used to detect the changes
in the slow wave activity of EEG [1]. Figure 6 represent the power density values
of EEG after drug administration. Peter Irwin has used 'Spectral difference index'
as a measure to determine whether a significant EEG change has occurred after
drug intervention [10]. He has used Spectral density index as a measure of the
difference between two relative power spectra (Figure 7). Coherence spectra can
be used as a measure of correlation between two simultaneous EEG records as a
function of frequency. Cross-spectrum is also of greater interest, which gives
information about the statistical interrelationship between two simultaneous
recorded EEG. The cross-spectrum is mathematically a complex quantity
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composed of cross spectral amplitudes, i.e. the average intensity of the activity
shared by two records as a function frequency and of the phase angle which
gives the average phase difference between common frequency components. The
coherence spectrum provides a measure of correlation between two EEG records
for each frequency band.
EEG power spectra in sleep
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Figure 5 The power spectra of all-night sleep record displayed in consecutive
samples of 20 sec
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Figure 6 The curves represent power density values in the 0.75-4.5 Hz range
plotted for 1-min epochs for a night following intake of flunitrazepam





An epoch-by-epoch approach is strongly recommended in all scoring and
characterization procedures. A convenient time interval for analysis has to be
selected. It should not be too short as to make the procedure cumbersome, nor so
long as to lose the variations. A convenient interval for most investigators would
be one page record, which is 300 mm. This interval would result in 20 to 30 sec
epoch time [11]. Once an epoch duration is selected it should be maintained for
the duration of analysis. During Wake stage alpha activity is of high or low
voltage amplitude. This stage is usually, but not necessarily, accompanied by a
relatively high tonic EMG, and often REMs and eye blinks are present in the
EOG tracing [11]. During this stage the EEG pattern variation may consist of
either decrease in amplitude, an increase in alpha activity, a paroxysmal burst of
high voltage activity, or the presence of EMG activity.
Stage 1 is defined by a relatively low voltage, mixed frequency EEG with
a prominence of activity in the 2-7 cps range. Stage 1 occurs most often in the
transition from wakefulness to the other sleep stages or following body
movements during sleep. The highest voltage about 50 - 75 microvolts [11] tends
to occur irregularly. This stage is characterized by the presence of slow eye
movements, each of several seconds duration. Rapid eye movements are absent.
Stage 2 is characterized by sleep spindles and K-complexes and the
absence of sufficient high amplitude. The total duration of the K-complex should




Stage 3 is defined by an EEG record in which at least 20% but not more
than 50% of the epoch consists of waves of 2 cps or slower which have amplitude
greater than 75 microvolts from peak to peak.
Stage 4 is defined by an EEG record in which more than 50% of the epoch
consists of waves of 2 cps or slower which have amplitudes greater than 75
microvolts peak to peak. Sleep spindles may or may not be present in this period.
Stage REM is defined by the concomitant appearance of relatively low
voltage, mixed frequency activity and episodic REMs. Alpha activity usually
somewhat predominant during stage REM than during stage 1. The frequency is
generally 1-2 cps slower than during wakefulness. There is an absolute absence
of sleep spindles and K complexes. Table 2 gives a concise form of criteria
mentioned above. Figure 8 illustrates the placement of electrodes and the onset




All-night EEGs, EOGs, and EMGs were recorded at the sleep laboratory of the
Robertwood Johnson Research Center from a 30 year old adult female suffering
from neurologic disorders. The recording was carried out in a sound-attenuated,
ventilated, temperature-controlled room. The data was recorded by Medilog
eight channel recorder for a period of six hours.
Two EEG channels (C3/A1 (Sz C4/ Al), two EOG channels (Al, one cm
vertically upward from outer canthus of left eye; Al, one cm vertically
downward from outer canthus of right eye), and one EMG channel (two
electrodes placed on the jawbone) were used which is schematically illustrated in
Figure 13. The five channel data obtained from the subject was amplified by
Table 2 Sleep stage scoring criteria
Stage W: 	 The EEG contains alpha activity associated with quiet wake-
fulness or low voltage activity with active wakefulness. The EMG
has a high level of activity and there are frequent voluntary eye
movements.
Stage 1: 	 The EEG shows less than half the epoch occupied by alpha waves.
No spindles or K-complexes occur in the EEG record. Occasional
slow, rolling eye movements occur.
Stage 2: 	 The EEG record shows K-complexes and bursts of 12 to 15 cycles
per second rhythm and contains less than 20 percent delta activity.
There are no eye movements.
Stage 3: 	 The EEG contains between 20 and 50 percent of the epoch oc-
cupied by delta activity. There are no eye movements.
Stage 4: 	 The EEG contains over 50 percent of the epoch occupied by delta
activity. There may be spindle activity superimposed on the delta
activity. There are no eye movements.
Stage REM: The EEG is relatively low voltage, mixed frequency activity with
bursts of theta rhythm and saw-tooth waves. Conjugate rapid eye
movements occur. The chin EMG reaches its lowest amplitude.
Al 	 RIGHT EYE - Al
C4 - Al






















Figure 10 Standard tracings of sleep EEG in stage 3 for four continuous 30 sec epoches
Figure 11 Standard tracings of sleep EEG in stage 4 for four continuous 30 sec epoches
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Figure 12 Schematic illustrations of starting of REM sleep
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Gould Universal amplifier with Band-pass filter across 0.3 to 100 Hz, and
continuously digitized at 256 Hz by a Data Translation Board. Figure 14 shows
the experimental setup.
3.2.2 Data Porting
The digitized data had to be transferred from the recording Center to the Sun
workstation which had the requisite tools for analysis. The binary data file, the
result of a six hour five channel recording was 66MB in size. Due to
nonavailability of INTERN-ET access at the time of this work, other means for
data transfer had to be thought of. An attempt to transfer the data through an
optical disk failed due to the mismatch of optical reader formats.
Alternative ways of transferring were through Floppy Disks, Laptop with
an ETHERNET card, Magnetic tapes etc. Storing onto floppy disks was not
feasible considering the size of the data. Laplink, a package which supports the
transfer of data between two computers, was used for this purpose. Laplink is a
sophisticated package having capabilities to transfer any form of data. Data can
be transferred to either a local or a remote machine. Local data transfer was
achieved at a rate of 33Kb/sec. The data was loaded onto the Sunsparc
mainframe using File Transfer Protocol. The binary file had to be converted into
a readable form. The size of converted file was three times its counterpart which
precluded its storage on the mainframe. Data Cartridge was employed to store
the 200MB of readable data.
3.3 Procedure
Analysis of overnight recording of EEG, EMG and EOG was performed on a Sun
Spark station. Matlab which supports mathematical and robust graphical
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Figure 14 Experimental setup for the data collection
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small lengths of data which are later stacked to get a overall picture of the signal.
Following the steps analysis was performed for various lengths of epoch. Due to
the enormous size of data and the following computational problems, to start
with a smaller length of signal was considered.
The basic approach in analyzing the data was by using the Fast Fourier
Transformation. Spectral analysis was the tool used to detect the variations in the
signal. The use of other orthogonal functions such as Walsh and Haar was also
considered but Fourier transformation was applied in the present study. Initially
the digitized and filtered data was preprocessed for analysis by removing the de
component. The dc component inherent in the signal was removed in two ways
depending upon the type of analysis. First the mean value was calculated for
each epoch and subtracted from the epoch amplitude. To say a few words about
the decision of epoch length, there are some standard approaches. Normally the
epoch length recommended is 30 seconds. There are other cases where smaller
durations have been considered. It is a customary to reduce the duration of
epoch when finer details within a given length is required. The 30 second epoch
is a practise to characterise long stretch of data. Continuing on the dc shift, the
mean value calculated for each epoch was applied on the same. The second way
was by calculating mean value for the whole length of data and subtracted from
each epoch. The data was reduced by 1000 times to get a realistic scale. Figure 15
shows a small stretch of demagnified data with its dc component reduced.
Various methods were considered to obtain spectral plots depicting subtle
changes in the behaviour of the signal. As a test epoch with a duration of 5 sec
was subjected into Fast Fourier Transformation (Routine FFT, Matlab
subroutine). A program was designed to read assigned length of data and to
perform the transformation. This routine was made to run over the whole length
of data. Consecutive power spectrums thus obtained were stacked onto a matrix
Figure 15 Sample EEG signal of two minutes used for analysis
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to get a complete picture of the nature of the signal. Figure 16 shows the power
spectrum of one such epoch. Figure 17 shows the 3D graph obtained through the
algorithm. Due to computational and memory restrictions the whole stretch
could not be depicted in the three dimensional form.
The overall power of data can be described by computing mean square
value, which is simply the average of the squared values of the time history. This
has been estimated for the whole length of data using an algorithm. It performs
this operation by calculating the square of each digitized sample and by
averaging it for a given length of epoch. The mean square value obtained for
each epoch is stored in an array. This array is used to plot a graph of mean
square variation with respect to time. The moving mean square model thus
obtained will be used for analysis and discussion in the later paragraph. Figure
18 shows the plot of mean square variation.
For nonstationary data, a basic statistical parameter is to estimate the
nonstationary mean value change with time. A similar algorithm as that of mean
square value has been used to get the mean value. It calculates the mean for each
epoch and stores in a form that can be used to plot the change with respect to
time. Figure 19 gives the output of this moving mean value model.
An epoch length of 30 sec was used. Mean power spectra was calculated
in two ways for each epoch. 15 spectras of consecutive 2 sec segments was
averaged to find the outcome of the 30 sec stretch of signal. This computation
resulted in 30 degrees of freedom. Another procedure was aimed at considering
the effect of history on the signal. Moving Power Spectral Analysis was carried
out by applying Fourier Transforms on overlapping data segments each of 30
seconds, divided and overlapped by 2 seconds (512 samples of data). The
spectral estimates were smoothed using Harming window in the frequency
domain. Figure 20 shows a moving power spectral model with this approach.
Figure 16 Power Spectrum of EEG for a thirty second epoch
Figure 17 Three dimensional plot of power spectra of one hour EEG
--.3
Figure 18 Mean square variation for a five hour EEG with a epoch length of 30sec.
Figure 19 Mean value variation for a five hour EEG with a epoch length of 30sec.
Figure 20 Power variation for a five hour EEG with a epoch length of 30sec.
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The same procedure was applied for the second EEG which has been derived
from a different part of the brain. Figure 21 shows the spectral graph of both
EEGs at the same section of time. This relational plot helps us in studying the
common properties and behaviour of the different sections of brain at the same
instant of time.
3.4 Results and discussions
This thesis presents a few results with spectral analysis of sleep activity. Because
of the large amount of computation various calculations had to be limited to
small lengths of data ranging up to 5 hours. Keeping this in mind the results of
analysis should be considered preliminary. A couple of questions that
immediately came to mind were the following. Is the technique of spectral
analysis a useful tool for characterization and does spectral analysis provide new
insights into the physiological mechanisms underlying the different EEG
patterns at different stages of sleep?
Spectral analysis if not the only tool, is atleast a good way to get a feel of
the composition and characteristics of signals like EEG. Spectra displays the
distribution of average intensity of the different frequency components. This also
allows us to quantify the background activity during various stages of sleep,
especially regarding frequency and intensity of peaks in the 8-, a-, cc- and 13-band.
Figure 21 will be the centre of discussion to figure out the variation of different
bands. 5 (0.25 - 2.0 hz) activity as expected increased its power as it passed from
awake to NREM. A peak in 5 band appears at around 1.5 hz during stage 2. Its
intensity increased as the subject got into the REM sleep. Something which can
be slightly noticed in the graph is the shift of the 6 peak to around 1.8 to 2.0 hz as
we get into REM. This means that the frequency has slowed down during the
REM stage. This slow wave activity can be noticed more dominantly in a
Figure 21 Averaged power spectra of EEG samples from various stages of left derivation is shown in
the left half. On the right half is the power spectra for the right derivation.
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conventional EEG, but not in this spectra. 0 activity (7 hz) is seen to be similar to
frequency that of 6 activity. The a activity (9.5 to 11 hz) is seen to be as expected
in the wake and in stage 1. In one of the papers it was mentioned that harmonic
distortion of the a activity was a frequent feature of healthy subjects. In this
analysis a great detail of a activity variation could not be noticed. The a activity
(13 and 15 hz) showed peaks during stages 2 and 3. A small peak can also be
observed during paradoxial sleep. 13 activity (20 to 30 hz) decreased its intensity
with increasing depth of sleep. Its intensity can be noticed during the initial
stages of sleep. In the three dimensional graph shown in figure 17 the activity of
J3 band can be noticed clearly in the initial part of the EEG recording. The moving
power spectra shown in figure 20 is a bit confusing. The activity of signal seems
to be quite varied. Even though the spectras at different stages relate to the
expected activity of EEG, the overall power variation does not follow the usual
pattern.
Before we discuss about the results mentioned above, it is important to
remember that phenomena like K-complexes are not dealt in this analysis. The
reason is due to the fact that its frequency content is spread over large parts of
the frequency scale which we are unable to detect by spectral analysis. Since the
activity of various bands are quantified by averaging for the analyzed epoch,
intermittent spindles with high amplitude are not clearly distinguishable. This
shows that spectral approach is not suitable for EEG classification schemes which
use K-complexes, vertex potentials and spindle shaped activity. Haar
transformation is another suitable technique for analysis due its superior
convergence property, but has the disadvantage of losing resolution in the
estimated power spectrum.
One of the contradicting observations was the existence of a activity in the
paradoxial sleep. Strong feeling that came about during this analysis was the lack
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of information regarding other activities that characterize EEG. This means to
say that spectral analysis alone cannot be used for characterization purpose.
Strong statistical tools and pattern recognition techniques are necessary. One of
the physiological remarks that can be made from the observations of two
recordings of EEG is the possibility of one source for certain components of the
signal. Close observation of figure 21 the variation of signal between 13 and 17
hz in both the recordings vary similarly. In the analysis performed long intervals
of time have been considered and an average spectrum has been calculated. This
long interval averaging has the disadvantage of ignoring the short-term changes.
The attempt to characterize the unexpected variation in the moving power
spectra for any possible drug effect was not successful. However the analysis on
this stretch of time was performed by choosing comparitively a smaller length.
Faster EEG waveforms that occur concurrently with slow-wave may not be
detected, unless certain filtering techniques are used.
APPENDIX A
MATLAB
MATLAB is a technical computing environment for high performance numeric
computation and visualization. MATLAB integrates numerical analysis, matrix
computation, signal processing, and graphics in an easy-to-use environment
where problems and solutions are expressed just as they are written
mathematically - without traditional programming.
The name MATLAB stands for matrix laboratory. MATLAB was originally
written to provide easy access to matrix software developed by UNPACK and
EISPACK projects, which together represent the state of the art in software for
matrix computation.
MATLAB is an interactive system whose base data element is a matrix that
does not require dimensioning. This allows you to solve many numerical
problems in a fraction of time it would take to write a program in a language
such as Fortran, Basic, or C.
MATLAB has evolved over a period of years with input from many users. In
university environments, it has become the standard instructional tool for
introductory courses in applied linear algebra, as well as advanced courses in
other areas. In industrial settings MATLAB is used for research and to solve
practical engineering and mathematical problems. Typical uses include general
purpose numeric computation, algorithm prototyping, and special purpose
problem solving with matrix formulations that arise in disciplines such as
automatic control theory, statistics, and digital signal processing.
MATLAB also features a family of application-specific solutions that it calls
as Toolboxes. Very important to most users of MATLAB, toolboxes are
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comprehensive collections of MATLAB functions(M-files) that extend the
MATLAB environment in order to solve particular classes of problems. Areas in
which toolboxes are available include signal processing, control system design,
dynamic systems simulation, systems identification, neural networks, and others.
Probably the most important feature of MATLAB, and the one that
MATLAB people took care to perfect, is its easy extensibility. This allows us to
become a contributing author too, creating our own applications. In the years
that MATLAB has been available, the company has enjoyed watching many
scientists, mathematicians, and engineers develop new and interesting
applications, all without writing a single line of low level code.
External Interfaces to MATLAB
Although MATLAB is a complete, self-contained environment for programming
and working with data, it is often very useful to interact with data and programs
external to MATLAB. Shell escape functions and MEX-files are the two methods
for calling your own C or Fortran subroutines.
a. Shell Escape Functions
Shell escape functions use shell escape command ! to make external stand alone
programs act like new MATLAB functions. A shell escape M-function is an M-
file that
1. Saves the appropriate variables on disk.
2. Runs an external program (which reads the external data file, processes the
data, and writes the result back out to disk).
3. Loads the processed file back into the workplace.
Shell escape functions are less efficient than MEX-files because they incur
the overhead associated with invoking an external program each time they are
called and because their arguments are passed via disk files. In situations where
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relatively large amount of processing is performed in the external program, this
overhead can be negligible, and converting to MEX-files offer no real advantage.
If the computation time of the external program is short compared to the
time spent loading the program and passing the variables, MEX-files may be
more suitable since the object code of a MEX-file is physically linked into
MATLAB.
b. Dynamically Linked Subroutines: MEX -Files
One can also call C and Fortran subroutines from MATLAB as if they were built-
in functions. MATLAB-callable C and Fortran programs are referred to as MEX-
files. MEX-files are dynamically linked subroutines that the MATLAB interpreter
can automatically load and execute. MEX-files have several applications:
1. Large pre-existing Fortran and C programs can be called from MATLAB
without having to be rewritten as M-files.
2. Bottleneck computations (usually for-loops) that do not run fast enough in
MATLAB can be recorded in C or Fortran for efficiency.
3. A/ D cards, D/A cards, and other hardware can be accessed directly for data
acquisition and control applications.
MEX-files are not appropriate for all applications. MEX-files offer an avenue
that unsuspecting users may follow when they would be much better of
programming in the MATLAB language. MATLAB is a high-productivity
system whose specialty is eliminating time consuming, low-level programming
in compiled languages like C and Fortran.
Techniques for importing and exporting data to and from the MATLAB
environment are also available. The most important approach is MAT-files-the
file format that MATLAB uses for saving data to disk. MAT-files offer a simple
and convenient mechanism for transporting our data between different
platforms.
APPENDIX B
"SIGNA" SIGNAL PROCESSING PACKAGE
The package supports a biomedical signals processing system. As a research tool
the system offers the potential to acquire and analyze experimental and clinical
data obtained in the form of photographs, polygraphic paper charts etc. In its
role as an adjunct to biomedical education, several self-teaching features are
implemented which enable the student of biomedical signals processing to gain
hands-on experience in the application of signals processing methodologies to
the analysis of clinical and experimental data. These features include a software
function generator and a help option. The modular approach employed in the
system design provides a great deal of flexibility to the investigator such that
when a new analysis is desired one can simply add on the particular user-
developed module to the system without causing any undue system constraints.
The types of analyses that are currently implemented include numerical
integration, curve fitting, Fourier, Walsh and Haar transformations, spectral
analysis and frequency response measurements. The system is being used for a
wide range of applications which include the analysis of electrical signals
generated at the neuromuscular junction, the computation of input impedance of
the arterial system, the analysis of pressure waveforms obtained during
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Table 3 Lists a few drugs and their effect on sleep. The column numbered through 1 through 4 refer to
control (+) of lack of control (0) for some major problems in drug research. These conclusions have
been made by analysing a portion of data less than the entire night.
Study Drug Subjects 1	 2	 3	 4 Results
Dunleavy et al. 	 (1971) Debrisoquine,
40 to 60 mg
3 normal + + + 	 0 Decreased rem; withdrawal rem rebound.
Cuanethidine, 40 mg 2 normal Decreased delta sleep.
Propanolol, 120 mg 1 normal No effect on sleep stages.
Haider and Oswald (1971) Amylobarbitone,
200 mg
6 normal 0 	 -I- 	 + 	 0  Decreased rem; increased stage 2.
Nitrazepam, 10 mg Decreased rem; increased stage 2.
Hartmann et al. (1971) Tryptophan,
120 mg/kg
10 normal + 0	 0 0 Increased rem sleep.
A. Kales et al. (1971) Levodopa 4 parkinson -1- + 	 0 	 0 Decreased rem sleep.
4 normal No effect on sleep stages.
j. Kales et al. 	 (1971) . Methapyrilene,
50 mg and
Scopolamine, 0.5 mg
5 insomnic + 0 + 0 Decreased rem in first part of night
only.
Kupfer et al. (1971) Chlorpromazine,
100 mg
9 mixed + 0 	 0 	 0 No effect on sleep stages; increased
total sleep time.
Lester et al. 	 (1971) Chlorpromazine,
150 mg
12 normal + + 0 0 No effect on sleep stages: decreased
latency to first rem period.
Wyatt et al. (1971b) Phenelzine,
60 mg/24 hr
6 mixed + 0 	 0 	 0 Total rem suppression without tolerance.
Wyatt et al. (1971c) 5-Hydroxytryptophan,
600 mg
8 normal + + 0 0 Increased rem sleep.
Study Drug Subjects 1 	 2 	 3 	 4 Results
Kales et al. 	 (1970f) Glutethimide, 500 mg 5 normal + 0 + 0 Decreased rem; increased stage 2;
withdrawal rem rebound.
Methyprylon, 300 mg 7 normal Decreased rem; withdrawal rem rebound.
Pentobarbital, 100 mg 4 normal Decreased delta sleep.
Kupfer et al. (1970b) Lithium, 1.8 gm/24 hr 7 manic-
depressive
+ + 0 0 Decreased rem; increased delta sleep




Diethylproprion, 25 mg Decreased rem sleep.
Amphetamine, 7.5 mg Decreased rem; increased stage 2.




+ 0 0 	 0 Decreased rem sleep.
Wyatt et al. (1970b) Tryptophan, 7.5 gm 5 normal + 0 	 0 	 0 Decreased rem; increased delta sleep.
7 insomnic No effect on sleep stages.
Baekeland and Lundwall (1971) Methyldopa,
1.25 gm/24 hr
10 normal + + + 0 Increased rein and decreased delta sleep
in first 3 hours only.
Coulter et al. 	 (1971) 	 . Reserpine, 1 mg 10 normal + 0 	 0 0 Increased rein and decreased delta
sleep on day after medication taken.
Study Drug Subjects 1	 2	 3	 4 Results
Evans and Ogunremi (1970) Chloral hydrate, 800 mg 4 normal 0 + 0 + Decreased rem sleep.
Dichloralphenazone,
1.3 gm
No effect on sleep stages.
Methaqualone,
250 mg and
No effect on sleep stages.
Diphenhydramine
25 mg
Firth et al. (1970) Fenfluramine, 40 mg 7 normal + + 0 0 No effect on sleep stages.
Kales et al. (1970b) Flurazepam, 30 mg 3 insomnic + 0 + 0 No effect on sleep stages.
Chloral hydrate 1 gm 4 insomnic No effect on sleep stages.
Glutethimide, 500 mg 4 insomnic Decreased rem; withdrawal rem rebound.
Kales et al. (1970d) Flurazepam, 30 mg 4 normal +0 	 + 	 0 No effect on sleep stages.
Flurazepam, 60 mg not given Decreased rem sleep.
Chloral hydrate, 1 gm 5 normal No effect on sleep stages.
Methaqualone, 300 gm 5 normal Decreased rem; withdrawal rem rebound.
Methaqualone, 150 mg 5 normal No effect on sleep stages.
Study Drug Subjects 1	 2	 3	 4 Results
Mebanazine, 15 mg I depressed Decreased rem; withdrawal rem rebound.
Phenelzine, 45 mg 1 depressed Decreased rem.
Pargyline, 100 mg 1 normal Decreased rem.
Zung (1969a) Desipramine, 75
mg/24 hr
6 depressed + 0 	 0 0 Increased delta sleep.
Zung (1969b) Desipramine, 75
mg/24 hr
17 normal Decreased rem and increased delta sleep
on fourth day of drug.
• • 	 • • . 	 • • • 	 •
Akindele et al. (1970) Nialimide, 10 mg/kg 5 normal + 0 + 0 No effect on sleep stages.
Phenelzine, 90 mg 4 normal Decreased rem; increased stage 2;
withdrawal rem rebound.
Phenelzine, 90 mg 3 depressed Decreased rem; increased delta sleep.
Bricolo et al. (1970) Levodopa, 4 gm/24 hr 14 parkinson + + 0 0 No effect on sleep stages.
Davison et al. (1970) Methaqualone, 250 mg
and Diphenhydramine,
25 mg





Study Drug Subjects 1	 2	 3	 4 Results
Sagales et al. 	 (1969) Scopolamine, 0.006
mg/kg
it 	 normal 0 + 	 0 	 0 Decreased rem sleep.
Chlorpromazine, 0.4
mg/kg
No effect on sleep stages.
II. L. Williams et al. (1969a) Reserpine, 1 mg 16 normal + + + 0 Increased rem on second drug night.
Tryptophan, 7.5 gm 11 normal Increased delta sleep.
Phenylalanine, 7.5 gm 11 normal Increased delta sleep.
H. L. Williams et al. (1969b) Alpha-chloralose,
AO mg
10 normal -I- 	 +	 0	 0 Decreased rem; increased delta sleep.
R. L. Williams and Agnew (1969) Pentobarbital, 200 mg 9 normal 0 + 0 + Decreased rem; increased stage 2.
Meprobamate, 800 mg No effect on sleep stages.
Glutethimide, 500 mg Decreased rem sleep.
Methaqualone, 300 mg No effect on sleep stages.
Wyatt et al. (1969a) Parachlorophenylalanine,
4 gm/24 hr
4 carcinoid + 	 0 	 0 	 0 Decreased rem with no tolerance.
Wyatt et al. (1969b) Isoniazid, 400 mg 1 normal + 0 + 0 No effect on sleep stages.
Isocarboxazid, 60 mg 1 normal Decreased rem sleep.
Study Drug Subjects 1	 2	 3	 4 Results
Brebbia et al. 	 (1969) Lithium, 1 gm/24 hr 6 mixed + + 0 0 No effect on sleep stages.
Feinberg et al. (1969e) Phenobarbital, 200 mg 6 mixed + + 0 0 Decreased rem sleep.
Chlorpromazine, 200 mg Decreased rem sleep.
Greenberg et al. (1969) Nitrous oxide by
inhalation
7 normal + 0 	 0 	 0 No effect on sleep stages
Haider (1969) Amylobarhitone, 200 mg 6 normal + + + 0 Decreased rem; increased stage 2.
Nitrazepam, 10 mg Decreased rem; increased stage 2.
Hoffman and Domino (1969) Reserpine, 0.14 mg/kg 20 prisoners + 0 	 0 	 0 Increased rem, prolonged effect.
Kales et al. (1969) Glutethimide, 500 mg 5 normal + + 0 0 Decreased rem; withdrawal rem rebound.
Methyprylon, 300 mg 7 normal Decreased rem; withdrawal rem rebound.
Chloral hydrate, 500 mg 10 normal No effect on sleep stages.
Lewis and Evans (1969) Chlorpromazine, 25 mg 7 normal + 	 ? 	 0 	 0 Increased rem after the first night.
Chlorpromazine, 100 mg Decreased rem sleep.
Rubin et al. (1969) Glutethimide, 1 gm 4 normal + 0 	 0 	 0 Decreased rent sleep.
Study Drug Subjects 1	 2	 3	 4 Results
Hartmann (1966) Reserpine, 2 mg 6 normal -I- 	 0 	 0 	 0 Increased rem sleep.
Lester and Guerrero-Figueroa
(1966)
Chlorpromazine, 100 mg 8 normal + 0 + 0 Increased delta sleep.
Alpha-chloralose,
500 mg
Decreased rem; increased delta sleep.
Phenobarbital, 120 mg Increased delta sleep.
Thiopental, 300 mg IV Decreased rem; increased delta sleep.
Muzio et al. (1966) LSD, 30 mcg 12 normal + 0 + 0 Increased rem in first part of night.
Oswald et al. (1966) Tryptophan, 5 gm 16 normal + + + 0 Increased rem (2 hr. recording only).
Toyoda (1966) Atropine, 10 mg 9 mixed -I- 	 0 	 + 	 0 No effect on sleep stages.
Yuko et al. (1966) Alcohol, 1 gm/kg 3 normal + + + 0 Decreased rem in first half of night;
rem rebound on withdrawai.
• •	 • • •	 • • • 	 •
Baekeland (1967) Pentobarbital, 100 mg 20 normal -I- 	 +	 + 	 -I- Decreased rem sleep.
Amphetamine, 15 mg Decreased rem sleep.
Hartmann (1967a) Tryptophan, 120 mg/kg 8 normal + 0 	 0 0 Increased rem; increased total sleep time.
Ritvo et al. (1967) Imipramine, 50 mg 7 enuretics 0 	 0 	 0 	 0 Decreased rem; increased stage 2 (first
drug night discarded).
Study Drug Subjects 1	 2	 3	 4 Results
Yules ct al. 	 (1967) Alcohol 1 gm/kg 4 normal + 	 ++ 	 0 Decreased rem; rem rebound on
withdrawal
• • 	 • • •	 • • • 	 •
Evans and Lewis, (1968) Amylobarbitone, 400 mg 2 normal + + 0 0 Decreased rem; rem rebound on
withdrawal; rem rebound blocked by
chlorpromazine.
Hartmann (1968b) - Pentobarbital, 100 mg 8 normal + + 0 0 Decreased rem sleep.
Amitryptyline, 75 mg Decreased rem sleep.
Chlordiazepoxide,
100 mg
No effect on sleep stages.
Knowles et al. (1968) Alcohol, 180 ml 1 normal + 0 + 0 Decreased rem in first half of night;
rem rebound on withdrawal.
Lester et al. 	 (1968) Secobarbital, 200 mg 14 normal + 0 + 0 No effect on rem; delta sleep increased in
first half of night, decreased in second
half.
Oswald et al. (1968) Diethylproprion, 50 mg 6 normal + + + 0 Decreased rem; withdrawal rem rebound 
(2 hr. recording).
Fenfluramine, 40 mg No effect on sleep stages (2 hr.
recordings).
Torda (1968) LSD, variable,
given during
third rem period.
2 normal 0 	 0 	 -I- 	 0 Decreased latency to fourth rem
period.
• • 	 • • • 	 • • • 	 •
Brannen and Jewett (1969) Promethazine, 50 mg 7 normal 0 + + 0 No effect on sleep stage percentages;
sleep cycle length increased.
Trifluoperazine, 5 mg Increased rem sleep.
Study Drug Subjects 1	 2	 3	 4 Results
Gresham et al. 	 (1963) Alcohol, 1 gm/kg 7 normal 0 + + 0 Decreased rem sleep.
Oswald et al. 	 (1963) Heptabarbitone, 400 mg 6 normal 0 	 0 	 + 0 Decreased rem sleep.
6 depressed
• • 	 . . 	 . 	 . • •
Rechtschaffen and Maron (1964) Amphetamine, 15 mg 8 normal + 	 + 	 0 	 0 Decreased rem; decreased total sleep time;
rem rebound upon drug withdrawal.
Toyoda (1964) Chlorpromazine, 50 mg 6 mixed + 	 +	 0 	 0 Increased rem sleep.
Imipramine, 50 mg Decreased rem sleep.
• • • • 	 • • • 	 •
Freemon et al. (1965) Meprobamate, 1200 mg 8 normal + + + + Decreased rem; increased stage 2.
Green (1965) LSD, 300 mcg 1	 alcoholic + + 	 +	 0 Increased rem sleep.
Oswald and Priest (1965) Amyloharbitone, 400 mg 4 normal + + + 0 Decreased rem sleep; withdrawal rem
rebound.
Nitrazepam, 15 mg Decreased rem sleep; withdrawal rem
rebound.
• • 	 • • • 	 • . 	 • 	 •
Baelceland (1966) Methylphenidate, 5 mg 6 normal + + + 0 Decreased rem; increased stage 2.
Evans and Oswald (1966) Tryptophan, 5 gm 7 narcoleptic + + 	 + 	 0 Increased rem (not an all-night
recording).
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